GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Concept Inc (NAS:VERO) » Definitions » Beneish M-Score

Venus Concept (Venus Concept) Beneish M-Score : -4.35 (As of May. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Venus Concept Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.35 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Venus Concept's Beneish M-Score or its related term are showing as below:

VERO' s Beneish M-Score Range Over the Past 10 Years
Min: -4.35   Med: -2.78   Max: 31.86
Current: -4.35

During the past 9 years, the highest Beneish M-Score of Venus Concept was 31.86. The lowest was -4.35. And the median was -2.78.


Venus Concept Beneish M-Score Historical Data

The historical data trend for Venus Concept's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Concept Beneish M-Score Chart

Venus Concept Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only 31.86 -3.42 -2.54 -3.14 -3.98

Venus Concept Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.61 -3.87 -3.67 -3.98 -4.35

Competitive Comparison of Venus Concept's Beneish M-Score

For the Medical Devices subindustry, Venus Concept's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Venus Concept's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Concept's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Venus Concept's Beneish M-Score falls into.



Venus Concept Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Venus Concept for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8898+0.528 * 0.9672+0.404 * 0.9066+0.892 * 0.783+0.115 * 0.8701
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.043+4.679 * -0.301354-0.327 * 1.2614
=-4.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $28.07 Mil.
Revenue was 17.479 + 18.132 + 17.616 + 20.075 = $73.30 Mil.
Gross Profit was 11.647 + 12.063 + 12.185 + 14.22 = $50.12 Mil.
Total Current Assets was $60.70 Mil.
Total Assets was $85.08 Mil.
Property, Plant and Equipment(Net PPE) was $5.31 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.08 Mil.
Selling, General, & Admin. Expense(SGA) was $70.68 Mil.
Total Current Liabilities was $29.45 Mil.
Long-Term Debt & Capital Lease Obligation was $75.40 Mil.
Net Income was -9.794 + -11.116 + -9.068 + -7.409 = $-37.39 Mil.
Non Operating Income was 0.294 + -1.463 + -0.91 + 0.179 = $-1.90 Mil.
Cash Flow from Operations was -2.878 + -0.774 + -4.075 + -2.122 = $-9.85 Mil.
Total Receivables was $40.29 Mil.
Revenue was 20.531 + 24.286 + 21.539 + 27.266 = $93.62 Mil.
Gross Profit was 13.699 + 15.789 + 13.373 + 19.046 = $61.91 Mil.
Total Current Assets was $77.74 Mil.
Total Assets was $112.81 Mil.
Property, Plant and Equipment(Net PPE) was $7.18 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.37 Mil.
Selling, General, & Admin. Expense(SGA) was $86.56 Mil.
Total Current Liabilities was $36.21 Mil.
Long-Term Debt & Capital Lease Obligation was $74.01 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(28.069 / 73.302) / (40.29 / 93.622)
=0.382923 / 0.430348
=0.8898

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(61.907 / 93.622) / (50.115 / 73.302)
=0.661244 / 0.683678
=0.9672

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (60.701 + 5.31) / 85.076) / (1 - (77.743 + 7.182) / 112.81)
=0.224094 / 0.247186
=0.9066

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=73.302 / 93.622
=0.783

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.369 / (4.369 + 7.182)) / (4.083 / (4.083 + 5.31))
=0.378236 / 0.434685
=0.8701

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(70.684 / 73.302) / (86.555 / 93.622)
=0.964285 / 0.924516
=1.043

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((75.398 + 29.448) / 85.076) / ((74.01 + 36.205) / 112.81)
=1.23238 / 0.976997
=1.2614

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-37.387 - -1.9 - -9.849) / 85.076
=-0.301354

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Venus Concept has a M-score of -4.35 suggests that the company is unlikely to be a manipulator.


Venus Concept Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Venus Concept's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Venus Concept (Venus Concept) Business Description

Traded in Other Exchanges
N/A
Address
235 Yorkland Boulevard, Suite 900, Toronto, ON, CAN, M2J 4Y8
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Heal, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
Executives
Anthony Natale director 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Ross Portaro officer: President Global Sales 235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Michael Willingham Masters 10 percent owner 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Silva Rajiv De director, officer: Chief Executive Officer 1400 ATWATER DRIVE, MALVERN PA 19355
Stanley Tyler Hollmig director 235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Hemanth Jacob Varghese officer: President/Chief Bus. Officer 330 JOICEY BOULEVARD, TORONTO A6 M5M2W1
Marlin Fund, Limited Partnership 10 percent owner MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Masters Capital Management Llc 10 percent owner 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Fund Iii, Limited Partnership 10 percent owner MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Master Fund Offshore Ii, Lp 10 percent owner WAYSTONE CORP SV (CAYMAN) LTD, STE 5B201, FL 2, 1 NEXUS WAY, CAMANA BAY, BOX 1344, GRAND CAYMAN E9 KY1-1108
Mss Vc Spv Lp 10 percent owner C/O MASTERS SPECIAL SITUATIONS, LLC, 3060 PEACHTREE ROAD, NW, STE.1425, ATLANTA GA 30305
Marlin Fund Ii, Limited Partnership 10 percent owner MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Masters Special Situations, Llc 10 percent owner 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Penna Domenic Della officer: Chief Financial Officer 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Anna Georgiadis officer: VP, Global HR 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8